PHARMACOSCOPY
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

PHARMACOSCOPY Trademark

Serial Number: 86353815 • Registration: 4925065

PHARMACOSCOPY is a trademark filed by CeMM - Forschungszentrum für Molekulare Medizin GmbH on July 31, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CeMM - Forschungszentrum für Molekulare Medizin GmbH (2 trademarks)

Lazarettgasse 14 / AKH BT 25.3

Entity Type: 99

Trademark Details

Filing Date

July 31, 2014

Registration Date

March 29, 2016

Published for Opposition

January 12, 2016

Cancellation Date

October 14, 2022

Goods & Services

Apparatus, namely, cell culture dishes used for cell culture, testing and/or detecting effects of drugs on cell types, in particular cells originating from blood or other tissues; scientific, optical, measuring and monitoring apparatus and instruments, namely, cell sorting devices, microscopes, photometers, and digital cameras; electric apparatus and instruments, namely, automated epi-fluorescent and confocal fluorescent microscopes for use in laboratories for medical purposes; computer-aided analysis apparatus and installations for receiving, processing, transmitting and displaying data constructed therefrom; computer hardware and computer software for processing, displaying, and interpreting data, in particular for scientific and medical purposes; test microtiter plates, namely, laboratory medical equipment for cell culture, testing, and/or detecting effects of drugs on cell types

Biochemical or chemical products for use in high-throughput screening assays for use in medical diagnosis and treatment; pharmaceutical and biochemical substances and preparations, in particular reagents for medical diagnosis of human diseases such as cancer, inflammation, and immune disorders; biochemical reagents for use in high-through put screening assays or chemical reagents for in vitro use in laboratories for medical purposes; chemical reagents for use in high-through put screening assays for in vitro use in laboratories for medical purposes; biochemical reagents for use in high-through put screening assays, or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells, in particular cells originating from blood or other tissues for medical use; diagnostic products, namely, reagents for medical purposes

Biochemical products for use in high-throughput screening assays or chemicals for use in industry and science; biochemical reagents or chemical reagents for in vitro use in laboratories for scientific use; biochemicals or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells other than for medical or veterinary use, in particular cells originating from blood or other tissues; in vitro diagnostic agents, namely, small molecules, polypeptides, antibodies, drugs, or other natural or laboratory-made products for scientific use; pharmaceutical and biochemical substances and preparations, in particular reagents for medical research

Medical and pharmaceutical research and development; scientific research and development services; industrial research in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; industrial development in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; laboratory services for cell culture, testing, and/or detecting the effects of drugs on cell types, in particular cells originating from blood or other tissues; professional consultancy services in the field of medical and pharmaceutical research and development; contract research services in the field of diagnosis and therapy of cancer, inflammation, and immune disorders; computer programming

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 14, 2022 C8..
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 15, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 15, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 15, 2022 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 29, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 29, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 24, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 4, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 23, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 23, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 23, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 23, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 10, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 3, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 19, 2015 PREV
ASSIGNED TO LIE
Oct 14, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 15, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 15, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 15, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 24, 2014 GNRN
NON-FINAL ACTION E-MAILED
Nov 24, 2014 GNRT
NON-FINAL ACTION WRITTEN
Nov 24, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2014 NWOS
NEW APPLICATION ENTERED
Aug 4, 2014 NWAP